In its latest round of awards, which brings the number of university research fellowships supported by the charity to 16, HOPE selected three projects that would benefit from PhD Studentships.
Professor David Lambert, Division of Pharmacology and Therapeutics, and Professor David Rowbotham, Department of Health Sciences, in collaboration with Drs Girolamo Calo and Remo Guerrini in Ferrara, Italy, are investigating the design and evaluation of new morphine-like analgesics with reduced side effects for long term use in cancer pain.
“Laboratory work has shown that this type of approach produces pain relief. We need to further refine the work to enable studies to be performed in patients. This will be a relatively long-term process (not within 3-5 years for example). However it offers a completely new approach to pain management. This particular project would not be possible without HOPE funding,” Professor Rowbotham said.
Dr Catrin Pritchard, Department of Biochemistry, is researching one of the major contributing factors in the development of human cancers and particularly colorectal cancer - the mutation of the BRAF proto-oncogene.
She explained the significance of the funding to her work: “Through the Hope Foundation fellowship we aim to utilize a technique called microarray to generate a “gene signature” for BRAF-induced cancers.
“Essentially this will provide us with an overview of all the gene expression changes that accompany the development of cancer following BRAF mutation in the gut and also following treatment with BRAF inhibitors.
“These studies are imperative as they will allow us to identify new effector genes involved in development of colorectal cancers, to track the efficacy of BRAF inhibition, and to identify if any resistance to the BRAF inhibitors is occurring.
“We are extremely grateful to receive funding from organizations like Hope Against Cancer, and really appreciate all the hard work that many people do to raise funds for our research.”
Dr Raffael Schaffrath, Department of Genetics, is analysing ovarian cancer at the molecular level to provide a means of improving the prevention, early diagnosis and treatment of patients or those who are at risk of developing the disease.
As a result of the HOPE funding, all three projects will now be able to appoint a PhD student dedicated to their research area. Dr Schaffrath expressed what that will mean to his project:
“Firstly, the HOPE project provides the funds for a talented young scientist who will receive expert training in a range of modern molecular and cellular technologies. He or she will be exposed to an exciting area of international cancer research and engaged in close interactions with other cancer researchers at the University of Leicester.
“Secondly, through HOPE, our research group as a whole will further develop its activities from basic science to biomedically relevant cancer research. So, we have a great chance to contribute further to cancer research conducted at the Department of Genetics, which is superbly equipped for all aspects of cellular and molecular biology, including genomics/proteomics facilities and state-of-the-art tissue culture and microscopy suites.
“I consider the HOPE project to be an excellent catalyst to enhance the research standards of our own group and to improve the reputation of the Department of Genetics, University of Leicester.”
This is the second round of PhD Studentships that Hope Against Cancer has funded. Lasting for three years, they enable PhD students to give more time to their research, as outgoing recipient of a Hope award, James Thorpe, explained: “In our group we are investigating whether chemicals from tea called polyphenols can prevent or delay prostate cancer.
“The funding that I have received from HOPE to maintain my research has allowed me to focus my efforts on cancer prevention. Prior to being funded, I was obliged to support my research by working 40 hours a week as a junior doctor. This limited the time available to concentrate on my research at a time when I was attempting to set up clinical trials.
“By being able to focus full time on cancer prevention experiments I have made much more progress than would otherwise have been possible. I have been able to extend the project into a third year. This will allow me to bring the work that I started to a conclusion and to write it up as a PhD. I am extremely grateful to HOPE for the support they gave to me personally and to cancer research in Leicestershire.”
Ather Mirza | alfa
Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences
What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy